Lung function and bronchial responsiveness after Mycoplasma pneumoniae infection in early childhood

Birgitte B Kjaer1, Jørgen S Jensen, Kim G Nielsen

  • 1Department of Paediatrics, Copenhagen University Hospital, Glostrup, Denmark. bbk@dadlnet.dk

Pediatric Pulmonology
|April 26, 2008
PubMed

Insights

Mycoplasma pneumoniae infection in early childhood did not impact long-term lung function or bronchial responsiveness. This study found no lasting respiratory effects in children infected with Mycoplasma pneumoniae.

Area of Science:

  • Pediatric Respiratory Medicine
  • Infectious Diseases
  • Pulmonology

Background:

  • Mycoplasma pneumoniae is linked to asthma exacerbations in children and adults.
  • Its etiological role in asthma development is under investigation.
  • Early childhood infections may influence long-term respiratory health.

Purpose of the Study:

  • To determine if Mycoplasma pneumoniae infection in early childhood affects long-term lung function.
  • To assess the influence of early Mycoplasma pneumoniae infection on bronchial responsiveness.
  • Investigating the lasting respiratory consequences of childhood Mycoplasma pneumoniae infections.

Main Methods:

  • Retrospective clinical cohort study of children under 5 years old.
  • PCR testing for Mycoplasma pneumoniae and other respiratory pathogens.
  • Lung function testing (specific airway resistance) and bronchial hyperresponsiveness assessment (cold, dry air hyperventilation).

Main Results:

  • Sixty-five children (28 PCR-positive, 37 PCR-negative for M. pneumoniae) completed follow-up.
  • No significant differences in baseline lung function between M. pneumoniae-positive and -negative groups (P=0.45).
  • No significant differences in bronchial response to cold, dry air hyperventilation between groups (P=0.42).

Conclusions:

  • Mycoplasma pneumoniae infection in early childhood is not associated with long-term lung function deficits.
  • Early childhood Mycoplasma pneumoniae infections do not appear to cause lasting bronchial hyperresponsiveness.
  • The study suggests no persistent negative respiratory effects from Mycoplasma pneumoniae in young children.

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...